Oral contraceptive use in women at increased risk of breast/ovarian cancer: knowledge and attitudes

Psychooncology. 2013 Jan;22(1):228-32. doi: 10.1002/pon.2049. Epub 2011 Sep 9.

Abstract

Background: Several of the health benefits and risks associated with the combined oral contraceptive pill (COCP) are particularly relevant to women at risk of hereditary breast and/or ovarian cancer.

Methods: Eighty-three past female patients of an Australian hereditary cancer clinic aged 18-50 years completed a self-report questionnaire to assess their contraceptive practices, knowledge and information needs (44% response rate).

Results: Ninety-two percent of participants had previously used the COCP, with a mean knowledge score of 3.63 out of 8. Nearly 40% reported that their family history of cancer was one reason they discontinued/avoided using the COCP. Women reported receiving insufficient COCP information and preferred a targeted information leaflet to answer their questions.

Conclusions: Although recall bias may have affected some women, there is a clear need to improve the consistency of information delivered to women at risk of hereditary breast and/or ovarian cancer, to ensure informed contraceptive choices are made.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Australia
  • Breast Neoplasms / genetics*
  • Contraception Behavior / statistics & numerical data*
  • Contraceptives, Oral, Combined / administration & dosage*
  • Female
  • Health Knowledge, Attitudes, Practice*
  • Humans
  • Middle Aged
  • Ovarian Neoplasms / genetics*
  • Risk Factors
  • Surveys and Questionnaires
  • Young Adult

Substances

  • Contraceptives, Oral, Combined